The real reason Europe's medicines industry is dying – POLITICO : vimarsana.com

The bloc risks becoming a drug importer rather than an innovator.

Related Keywords

Wellington , New Zealand General , New Zealand , China , New York , United States , Beijing , Brussels , Bruxelles Capitale , Belgium , Boston , Massachusetts , Germany , Munich , Bayern , America , American , Americans , German , Olivier Wouters , Eli Lilly , Laura Gutierrez , Susana Sol , Ralf Huss , European Commission , European Federation Of Pharmaceutical Industries , London School Of Economics , European Union , Johnson , Drug Administration , Novo Nordisk , Renew Europe , European Federation , Pharmaceutical Industries , London School , Silicon Valley , Wellington Partners , Atlas Ventures , Northern Bavaria , Biom Biotech Cluster , Agatha Christie , Paris Based Sanofi , Atmps , Biotechnology , Business And Competition , Cancer , Data , Drug And Device Safety , Industry , Investment , Major And Chronic Diseases , Markets , Medicines , Meps , Patients , Pharma , Regulatory , Research , Research And Development , Susana Solís Pérez , Switzerland , Tax , Technology , Vaccines , Venture Capital ,